Clinical Research job market in Russia

Russia is an important market for global pharmaceutical industry players due to its huge growth potential. That being said, the Russian pharmaceutical industry is a currently very fragmented with no clear-cut dominance market leader, and the top ten drug manufacturers collectively account for about 40 percent of the market value. 

In terms of employment, the Russian Pharmaceutical Market can be divided broadly into two major segments:

The Commercial Segment:

This segment includes retail drug sales and ‘Para-Pharmaceuticals’ (health and beauty products and other non-medicinal products) but excludes medical drug sales under the Federal Reimbursement program (FRP). The segment forms about 70 percent of the market by value.

The State-owned Segment:

This segment includes sales of medicines through pharmacies under the FRP program, as well as sales through various prevention and treatment facilities and clinical chains. The segment accounts for about 30 percent of the market value.